NCT03995342

Brief Summary

The study aim to evaluate the improvement and correlation of soluble dietary fiber (prebiotics) in the frailty of elderly people by a randomized, double-blind, placebo-controlled clinical trial.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

5.4 years

First QC Date

June 10, 2019

Last Update Submit

July 15, 2024

Conditions

Keywords

frailty, flora

Outcome Measures

Primary Outcomes (1)

  • Improvement of frailty

    Frailty will be diagnosed according to Fried criteria

    3 months

Secondary Outcomes (1)

  • Diversity analysis of intestinal flora

    3 months

Study Arms (2)

exprimental: Inulin

EXPERIMENTAL

Inulin 15 grams after dissolution by mouth, every morning for three months.

Dietary Supplement: Inulin

Active comparator: maltodextrin

PLACEBO COMPARATOR

Placebo (maltodextrin) 15grams after dissolution by mouth, every morning for three months.

Dietary Supplement: Maltodextrin

Interventions

InulinDIETARY_SUPPLEMENT

Inulin 15 grams after dissolution by mouth, every morning for three months.

exprimental: Inulin
MaltodextrinDIETARY_SUPPLEMENT

Placebo (maltodextrin) 15g/d,Oral administration after dissolution15g/d,Oral administration after dissolution

Also known as: Placebo
Active comparator: maltodextrin

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥65 years;
  • Can get up from a chair and walk 6 meters
  • Clearly consciousness, able to read or use words to express and communicate without difficulty
  • Agree and accept the study plan

You may not qualify if:

  • Acute and chronic inflammatory disease of the intestine within 3 months
  • Use of antibiotics, probiotics, prebiotics or synthetics, laxatives or diarrhea medications, proton pump inhibitors or gastric motility drugs within 1 month
  • Dementia
  • mental illness or blindness
  • acute infection
  • cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing Hospital

Xi'an, Shaanxi, 710032, China

Location

Related Publications (1)

  • Yang J, Hou L, Wang A, Shang L, Jia X, Xu R, Wang X. Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial. J Clin Invest. 2024 Aug 6;134(18):e176507. doi: 10.1172/JCI176507.

MeSH Terms

Conditions

Frailty

Interventions

Inulinmaltodextrin

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesFructansPolysaccharides

Study Officials

  • Wang xiao ming

    Director of geriatrics

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of geriatrics

Study Record Dates

First Submitted

June 10, 2019

First Posted

June 24, 2019

Study Start

August 1, 2019

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

We will not make individual participant data (IPD) available to other researchers in a few years.

Locations